栖息地放射组学分析与肿瘤生态系统多样化结合:照亮非肌层浸润性膀胱癌术后复发评估的新策略
本研究回顾性纳入两家医疗机构2015至2021年的382例非肌层浸润性膀胱癌患者,基于三期CT图像对肿瘤区域行K-means聚类识别瘤内栖息地并提取放射组学特征,构建栖息地模型预测两年复发,训练队列AUC为0.932(95%CI: 0.906-0.958),验证队列AUC为0.782(95%CI: 0.674-0.890),且与肿瘤-间质比显著相关。
要点
- 基于三期CT的瘤内栖息地放射组学模型预测NMIBC两年复发,训练队列AUC 0.932、验证队列AUC 0.782。
- HBM诊断效能优于临床模型(p < 0.001,训练队列),多相放射组学模型与临床模型无显著差异(p = 0.130)。
- HBM评分可区分无复发生存,并与肿瘤-间质比显著相关。
核心结论
- 基于栖息地的放射组学结合机器学习可有效预测非肌层浸润性膀胱癌复发,进一步研究栖息地放射组学有望改善NMIBC的临床管理。
研究设计与样本
- 回顾性研究,纳入两家医疗机构2015至2021年的382例NMIBC患者,采集三期CT图像并在膀胱内勾画肿瘤部位。
关键影像表现/征象
- 在NMIBC中识别出三个不同的栖息地。
- HBM预测两年复发训练队列AUC 0.932(95%CI: 0.906-0.958)、验证队列AUC 0.782(95%CI: 0.674-0.890)。
- HBM诊断效能优于临床模型(p < 0.001,训练队列)。
- 多相放射组学模型与临床模型无显著差异(p = 0.130,训练队列)。
- HBM评分可有效区分NMIBC患者的无复发生存,并与肿瘤-间质比显著相关。
诊断标准与关键数值
- 采用K-means聚类对肿瘤部位的19个纹理特征识别瘤内栖息地。
- 每个栖息地以PyRadiomics提取107个放射组学特征并整合入机器学习算法构建HBM。
- 以两年复发为预测目标,训练队列HBM的AUC为0.932(95%CI: 0.906-0.958)、验证队列为0.782(95%CI: 0.674-0.890)。
临床应用与阅片要点
- 基于三期CT图像勾画膀胱内肿瘤部位并按纹理特征聚类划分栖息地,用于预测NMIBC两年复发风险。
- HBM在训练队列中诊断效能优于临床模型(p < 0.001),多相放射组学模型与临床模型无显著差异(p = 0.130)。
- HBM评分与无复发生存及肿瘤-间质比相关,作者认为进一步研究栖息地放射组学有望改善NMIBC临床管理。
局限性
- 原文结论指出需进一步研究栖息地放射组学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Non-muscle-invasive bladder cancer (NMIBC) is highly recurrent, with each recurrence potentially progressing to muscle-invasive cancer, affecting patient prognosis. Intratumoral heterogeneity plays a crucial role in NMIBC recurrence. This study investigated a novel habitat-based radiomic analysis for stratifying NMIBC recurrence risk.
MATERIALS AND METHODS: A retrospective collection of 382 NMIBC patients between 2015 and 2021 from two medical institutions was carried out. Patients' CT images were collected across three phases, with tumor sites delineated within the bladder. Intratumoral habitats were identified using K-means clustering on 19 texture features of the tumor sites, followed by the extraction of 107 radiomic features per habitat with PyRadiomics. These features were integrated into machine learning algorithms to develop a habitat-based model (HBM) for predicting two-year recurrence of NMIBC patients. The clinical and multiphase radiomic models were also constructed for comparison, with the Delong test comparing their diagnostic efficiency. The impact of HMB on patients' recurrence-free survival and the correlation between HBM and tumor-stroma ratio were further analyzed.
RESULTS: Three distinct habitats were identified within NMIBC. The HBM showed an AUC of 0.932 (95% CI: 0.906 - 0.958) in the training cohort and 0.782 (95% CI: 0.674 - 0.890) in the validation cohort for predicting two-year recurrence. With comparison between different models, The HBM is demonstrated to possess superior diagnostic efficacy to the clinical model (p < 0.001) in the training cohort. However, no significant difference was noted between the multiphase and clinical models (p = 0.130) in the training cohort. The HBM score effectively distinguished the recurrence-free survival of NIMBC patients and demonstrated a significant correlation with the tumor-stroma ratio.
CONCLUSIONS: Habitat-based radiomics, coupled with machine learning, efficiently predicts NMIBC recurrence. Further research on habitat-based radiomics offers potential improvement in clinical management of NMIBC.
引用
- Li H, Sui Y, Tao Y, et al. Coupling Habitat Radiomic Analysis with the Diversification of the Tumor ecosystem: Illuminating New Strategy in the Assessment of Postoperative Recurrence of Non-Muscle Invasive Bladder Cancer. Acad Radiol. 2024. PMID: 39455346. doi:10.1016/j.acra.2024.09.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。